Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease
Top Cited Papers
Open Access
- 5 January 2024
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 14 (1) , 1-8
Abstract
Breakdown of the neurovascular unit is associated with blood-brain barrier (BBB) leakiness contributing to cognitive decline and disease pathology in the early stages of Alzheimer’s disease (AD). Vascular stability depends on angiopoietin-1 (ANGPT-1) signalling, antagonised by angiopoietin-2 (ANGPT-2) expressed upon endothelial injury. We examined the relationship between CSF ANGPT-2 and CSF markers of BBB leakiness and core AD biomarkers across three independent cohorts: (i) 31 AD patients and 33 healthy controls grouped according to their biomarker profile (i.e., AD cases t-tau > 400 pg/mL, p-tau > 60 pg/mL and Aβ42 < 550 pg/mL); (ii) 121 participants in the Wisconsin Registry for Alzheimer’s Prevention or Wisconsin Alzheimer’s Disease Research study (84 participants cognitively unimpaired (CU) enriched for a parental history of AD, 20 participants with mild cognitive impairment (MCI), and 17 with AD); (iii) a neurologically normal cohort aged 23–78 years with paired CSF and serum samples. CSF ANGPT-2, sPDGFRβ, albumin and fibrinogen levels were measured by sandwich ELISA. In cohort (i), CSF ANGPT-2 was elevated in AD and correlated with CSF t-tau and p-tau181 but not Aβ42. ANGPT-2 also correlated positively with CSF sPDGFRβ and fibrinogen – markers of pericyte injury and BBB leakiness. In cohort (ii), CSF ANGPT-2 was highest in MCI and correlated with CSF albumin in the CU and MCI cohorts but not in AD. CSF ANGPT-2 also correlated with CSF t-tau and p-tau and with markers of neuronal injury (neurogranin and α-synuclein) and neuroinflammation (GFAP and YKL-40). In cohort (iii), CSF ANGPT-2 correlated strongly with the CSF/serum albumin ratio. Serum ANGPT-2 showed non-significant positive associations with CSF ANGPT-2 and the CSF/serum albumin ratio. Together, these data indicate that CSF and possibly serum ANGPT-2 is associated with BBB leakiness in early AD and is closely related to tau pathology and neuronal injury. The utility of serum ANGPT-2 as a biomarker of BBB damage in AD requires further study.Keywords
All Related Versions
Funding Information
- Alzheimer’s Research UK (ARUK-SRF2019A-001)
This publication has 44 references indexed in Scilit:
- Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrierJournal of Clinical Investigation, 2015
- Blood-Brain Barrier Breakdown in the Aging Human HippocampusNeuron, 2015
- Phosphorylated Tau-Aβ42 Ratio as a Continuous Trait for Biomarker Discovery for Early-Stage Alzheimer’s Disease in Multiplex Immunoassay Panels of Cerebrospinal FluidBiological Psychiatry, 2014
- Poor glycemic control associates with high intravitreal angiopoietin‐2 levels in patients with diabetic retinopathyActa Ophthalmologica, 2014
- Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathyAnnals of Neurology, 2009
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyThe Lancet Neurology, 2006
- Increased angiopoietin2 expression is associated with endothelial apoptosis and blood–brain barrier breakdownLaboratory Investigation, 2005
- Angiopoietin-2 and rat brain capillary remodeling during adaptation and deadaptation to prolonged mild hypoxiaJournal of Applied Physiology, 2002
- Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivoProceedings of the National Academy of Sciences, 2002
- Hypoxia-Inducible Angiopoietin-2 Expression Is Mimicked by Iodonium Compounds and Occurs in the Rat Brain and Skin in Response to Systemic Hypoxia and Tissue IschemiaThe American Journal of Pathology, 2000